Viridian Therapeutics, Inc. VRDN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

56/100

2/7 Pass

SharesGrow Intrinsic Value

Viridian Therapeutics, Inc. (VRDN) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は Logos Global Master Fund LP 6,000,000 株保有. その他の主要保有者には Fairmount Funds Management LLC および Atlas Venture Fund VII L P.

過去12ヶ月間にインサイダーは 25 件の取引を実施 VRDN 株式 — 12 件の買い (評価額 $11.82M) および 1 件の売り (評価額 $70.8K). インサイダーの買いが売りを上回っており、会社の見通しに対する自信の表れかもしれません.

VRDN インサイダー保有状況

最大保有者

Logos Global Master Fund LP

6,000,000 株

買い（12ヶ月）

$11.82M 評価額

売り（12ヶ月）

$70.8K 評価額

12ヶ月取引活動

買い 48%

売り 4%

インサイダー上位保有者

#	氏名	役職	保有株数	最終申告日	相対規模
1	Logos Global Master Fund Lp	10 Percent Owner	6,000,000	2020-11-16	100%
2	Fairmount Funds Management Llc	10 Percent Owner	3,914,458	2025-10-27	65%
3	Atlas Venture Fund Vii L P	10 Percent Owner	3,142,580	2017-02-13	52%
4	Remeditex Ventures Llc	10 Percent Owner	2,706,563	2017-02-13	45%
5	Frazier Life Sciences Public Fund, L.p.	10 Percent Owner	1,505,200	2021-09-28	25%
6	Fairmount Healthcare Fund Ii L.p.	Director	1,363,764	2022-08-19	23%
7	Marshall William Stuart	President & CEO	464,000	2020-02-14	8%
8	Point72 Asset Management, L.p.	10 Percent Owner	426,162	2020-11-20	7%
9	Ra Capital Management, L.p.	10 Percent Owner	410,686	2020-12-17	7%
10	Leverone Jason A.	Chief Financial Officer	311,785	2021-01-20	5%
11	Escolar Diana	Chief Medical Officer	270,000	2020-02-14	5%
12	Myers Scott Dunseth	Chief Executive Officer	259,500	2023-04-12	4%
13	Violin Jonathan	Chief Executive Officer	239,205	2023-02-07	4%
14	Riccitelli Samuel D	President & CEO	200,000	2016-05-19	3%
15	Katz Barrett	Chief Medical Officer	108,000	2023-02-10	2%
16	Humer Kristian	CFO and Cbo	108,000	2023-02-10	2%
17	Rubin Paul D	EVP, Research & Development	87,000	2019-02-08	1%
18	Levy Adam Scott	Chief Business Officer	74,000	2019-02-08	1%
19	Melvin Carrie	COO	54,000	2023-02-10	1%
20	Ciulla Thomas	Chief Medical Officer	50,000	2024-02-07	1%

最近の取引 (過去12ヶ月)

日付	氏名	役職	種類	株数	株価	価値
2026-03-03	Tousignant Jennifer	Chief Legal Officer	RSU 源泉徴収	1,675	$30.19	$50.57K
2026-03-03	Harmon Seth	Chief Financial Officer	RSU 源泉徴収	2,031	$30.19	$61.32K
2026-03-03	Mahoney Stephen F.	President and CEO	RSU 源泉徴収	7,408	$30.19	$223.65K
2026-03-03	Beetham Thomas W.	Chief Operating Officer	RSU 源泉徴収	3,048	$30.19	$92.02K
2026-03-03	Tousignant Jennifer	Chief Legal Officer	RSU 源泉徴収	1,724	$29.32	$50.55K
2026-03-02	Tousignant Jennifer	Chief Legal Officer	RSU 付与（制限付株式）	23,850	-	-
2025-03-03	Tousignant Jennifer	Officer	不明	-	-	-
2026-03-03	Harmon Seth	Chief Financial Officer	RSU 源泉徴収	2,091	$29.32	$61.31K
2026-03-02	Harmon Seth	Chief Financial Officer	RSU 付与（制限付株式）	20,550	-	-
2025-03-03	Harmon Seth	Officer	不明	-	-	-
2026-03-02	Tripuraneni Radhika	Chief Medical Officer	RSU 付与（制限付株式）	19,150	-	-
2026-03-03	Mahoney Stephen F.	President and CEO	RSU 源泉徴収	7,627	$29.32	$223.62K
2026-03-02	Mahoney Stephen F.	President and CEO	RSU 付与（制限付株式）	111,900	-	-
2026-03-03	Beetham Thomas W.	Chief Operating Officer	RSU 源泉徴収	3,138	$29.32	$92.01K
2026-03-02	Beetham Thomas W.	Chief Operating Officer	RSU 付与（制限付株式）	35,300	-	-
2025-12-31	Tousignant Jennifer	Chief Legal Officer	情報に基づく売り	2,272	$31.16	$70.8K
2025-10-23	Fairmount Funds Management Llc	10 Percent Owner	情報に基づく買い	454,545	$22.00	$10M
2025-07-01	Gheuens Sarah	Director	RSU 付与（制限付株式）	21,000	$14.47	$303.87K
2025-07-01	Kiselak Tomas	Director	RSU 付与（制限付株式）	21,000	$14.47	$303.87K
2025-07-01	Cain Christopher W.	Director	RSU 付与（制限付株式）	21,000	$14.47	$303.87K
2025-07-01	Moses Jennifer K.	Director	RSU 付与（制限付株式）	21,000	$14.47	$303.87K
2025-07-01	Ajer Jeffrey Robert	Director	RSU 付与（制限付株式）	21,000	$14.47	$303.87K
2025-07-01	Morris Arlene	Director	RSU 付与（制限付株式）	21,000	$14.47	$303.87K
2025-06-10	Fairmount Funds Management Llc	10 Percent Owner	オプション行使（売却）	12,500	$12.31	$153.88K
2025-06-09	Fairmount Funds Management Llc	10 Percent Owner	オプション行使（売却）	1,600	$7.80	$12.48K